Amdocs Limited (NASDAQ:DOX) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB cut its holdings in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 28.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 124,700 shares of the technology company's stock after selling 50,750 shares during the period. Handelsbanken Fonder AB owned approximately 0.11% of Amdocs worth $10,960,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Financiere des Professionnels Fonds d investissement inc. lifted its holdings in Amdocs by 1.3% in the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company's stock valued at $860,000 after acquiring an additional 130 shares during the period. First Eagle Investment Management LLC boosted its stake in shares of Amdocs by 6.3% during the 3rd quarter. First Eagle Investment Management LLC now owns 2,448 shares of the technology company's stock worth $207,000 after acquiring an additional 145 shares during the last quarter. CI Investments Inc. grew its position in shares of Amdocs by 0.7% during the 3rd quarter. CI Investments Inc. now owns 21,000 shares of the technology company's stock valued at $1,774,000 after acquiring an additional 152 shares during the period. Balentine LLC increased its stake in shares of Amdocs by 5.3% in the 3rd quarter. Balentine LLC now owns 3,050 shares of the technology company's stock worth $258,000 after purchasing an additional 153 shares in the last quarter. Finally, Wahed Invest LLC increased its stake in shares of Amdocs by 9.8% in the 3rd quarter. Wahed Invest LLC now owns 1,870 shares of the technology company's stock worth $158,000 after purchasing an additional 167 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors.

Amdocs Trading Down 1.3 %

Shares of DOX stock traded down $1.10 on Thursday, reaching $85.64. 518,118 shares of the company's stock were exchanged, compared to its average volume of 649,953. The company's fifty day simple moving average is $89.86 and its 200 day simple moving average is $87.32. Amdocs Limited has a 52 week low of $78.38 and a 52 week high of $99.75. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $10.07 billion, a PE ratio of 18.37, a P/E/G ratio of 1.41 and a beta of 0.69.

Amdocs (NASDAQ:DOX - Get Free Report) last released its earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.16. The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The business's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the company earned $1.33 earnings per share. As a group, analysts forecast that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a dividend of $0.479 per share. The ex-dividend date is Wednesday, March 27th. This is a positive change from Amdocs's previous quarterly dividend of $0.44. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.24%. Amdocs's dividend payout ratio (DPR) is 41.11%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, March 15th. Barclays lifted their price target on shares of Amdocs from $105.00 to $115.00 and gave the company an "overweight" rating in a report on Thursday, February 8th. Finally, Citigroup raised their price objective on Amdocs from $96.00 to $104.00 and gave the company a "buy" rating in a research note on Wednesday, January 17th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Amdocs presently has a consensus rating of "Buy" and a consensus price target of $108.60.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.